# REGENXBIO Inc.: Form 8-K, filed Mar 13, 2025

- Company: [REGENXBIO Inc.](/companies/rgnx.md) (CIK 1590877)
- Form: 8-K
- Filed: 2025-03-13
- Accepted by EDGAR: Mar 13, 2025, 16:05 ET
- Period: 2025-03-13
- Accession: 0000950170-25-038711
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590877/000095017025038711/rgnx-20250313.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590877/000095017025038711/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1590877/000095017025038711/rgnx-20250313.htm

Filed Mar 13, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-038711. Last ingested by Listed: Nov 5, 2026, 12:01 ET. No prices; not investment advice.